Drug giant Pfizer aims to buy Botox-maker Allergan in $160bn deal 23-Nov-2015 By Simon Pitman US pharmaceuticals player Pfizer has agreed to buy Botox-maker Allergan for an estimated $160bn in a deal that will create the largest drug-maker in the world.